+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Imaging Reagent Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Biological Imaging Reagent Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Biological Imaging Reagent Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011393
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Imaging Reagent Market grew from USD 17.61 billion in 2024 to USD 18.94 billion in 2025. It is expected to continue growing at a CAGR of 7.22%, reaching USD 26.77 billion by 2030.

Charting the New Frontier of Biological Imaging Reagents

Biological imaging reagents have emerged as indispensable tools for unlocking the intricacies of living systems, driving breakthroughs across drug discovery, diagnostics, and fundamental research. This executive summary introduces the critical role that antibodies, enzymes, fluorescent dyes, probes, and stains play in visualizing molecular and cellular processes. With advanced technologies demanding ever-greater sensitivity, specificity, and quantitative accuracy, imaging reagents form the backbone of experimental workflows, enabling scientists to translate molecular interactions into meaningful visual data.

In recent years, the growing intersection of imaging with artificial intelligence, high-throughput screening, and multiplex analysis has elevated the importance of reagent innovation. Stakeholders across academia, clinical diagnostics, and the pharmaceutical sector rely on these reagents to accelerate timelines, improve decision-making, and reduce costs. This introduction frames the ensuing discussion by highlighting how reagent performance underpins the modernization of biological imaging platforms and sets the stage for examining the transformative shifts, regulatory impacts, and strategic segmentation that define the current landscape.

Evolution of the Biological Imaging Landscape in the Digital Era

The biological imaging landscape is being reshaped by advances in resolution, throughput, and data analytics. Super-resolution microscopy methodologies have graduated from specialized laboratories into mainstream applications, challenging reagent developers to deliver dyes and probes with unprecedented photostability and brightness. Concurrently, the integration of machine learning into image analysis workflows has fueled demand for reagents that generate reproducible, high-contrast signals suited for algorithmic processing.

Meanwhile, single-cell and spatially resolved techniques are driving a shift toward multiplexed assays capable of probing multiple biomarkers in the same sample. This push has spurred the evolution of fluorescent dyes into spectral multiplexing formats and the rise of barcoded probes for sequential imaging. Alongside these technological leaps, the democratization of open-source hardware and cloud-based imaging platforms is broadening access to advanced microscopy, prompting reagent suppliers to develop standardized kits and automated labeling protocols that simplify complex workflows.

Assessing the Ripple Effects of 2025 US Tariffs on Supply Chains

The tariff adjustments implemented by the United States in 2025 have introduced new cost dynamics across the imaging reagent supply chain. Increases on imports of key consumables and raw materials prompted both manufacturers and end users to reassess sourcing strategies. Academic institutions, clinical laboratories, and pharmaceutical enterprises experienced elevated reagent pricing, which in turn led to tighter budget allocations and prioritization of high-impact experiments.

In response, reagent producers initiated supply chain diversification, securing alternative manufacturing bases in low-tariff jurisdictions and renegotiating contracts to mitigate the impact on customers. Some research laboratories adopted just-in-time inventory models, reducing storage overhead while ensuring continuity of critical assays. The cumulative effect has been a recalibration of value propositions, with suppliers emphasizing total cost of ownership, reliability of supply, and bundled service offerings to offset the burden of increased import duties.

Decoding Market Segmentation for Strategic Advantage

A detailed understanding of market segmentation reveals nuanced opportunities and challenges across product type, technology, application, and end user. Within product type, antibodies remain the cornerstone of immunolabeling applications, with primary antibodies offering targeted specificity and secondary antibodies providing signal amplification. Enzymatic reagents, including kinase and protease families, play a pivotal role in activity assays, enabling functional insights into cellular signaling pathways. Advanced fluorescent dyes, spanning organic molecules to quantum dots, cater to requirements for exceptional brightness and photostability, while nucleic acid probes for DNA and RNA support spatial transcriptomics and in situ hybridization. Traditional stains, from Gram reagents to hematoxylin and eosin, continue to underpin histological analyses, evolving toward rapid staining kits optimized for digital pathology.

On the technology front, bioluminescence reagents such as ATP assays and luciferase substrates offer remarkable sensitivity for quantifying cellular viability and gene expression. Chemiluminescence platforms powered by enhanced ECL kits and HRP substrates enable low-background detection in immunoassays. Colorimetric assays, characterized by Bradford protein reagents and ELISA kits, deliver robustness and ease of interpretation, serving as workhorse tools in many laboratories. Fluorescence microscopy reagents, from FISH probes to immunofluorescence conjugates, facilitate high-resolution mapping of biomolecules within complex samples.

The application dimension uncovers use cases in cell biology, where apoptosis and cell viability assays inform on therapeutic toxicity and regenerative processes. Drug discovery workflows leverage high-throughput screening reagents and screening assay kits to accelerate hit identification and lead optimization. Molecular biology experiments depend on PCR reagents for nucleic acid amplification and Western blot reagents for protein detection. In pathology, FISH probes and IHC reagents drive precision diagnostics by correlating genetic markers and protein expression with clinical outcomes.

End users span academic and research institutes-including dedicated research organizations and leading universities-hospitals and diagnostic laboratories encompassing clinical and pathology laboratories, as well as pharmaceutical and biotechnology companies operating across large integrated enterprises and specialized outsourcing service providers. Each segment exhibits distinct purchasing behaviors, regulatory requirements, and performance expectations that inform product development and go-to-market strategies.

Regional Dynamics Shaping the Imaging Reagent Ecosystem

Regional nuances exert a profound influence on reagent demand, regulatory landscapes, and competitive dynamics. In the Americas, robust funding for academic research and a concentration of leading biotechnology hubs underpin high uptake of cutting-edge imaging reagents. Regulatory frameworks emphasize quality assurance and traceability, prompting suppliers to invest in certified manufacturing and detailed documentation to satisfy compliance requirements.

The Europe, Middle East & Africa region presents a heterogeneous tapestry of market conditions, from well-established research centers in Western Europe to emerging life sciences clusters in the Gulf and North Africa. Variations in health care infrastructure, reimbursement policies, and import regulations necessitate tailored market entry approaches and pricing models. Reagent providers often form strategic alliances with local distributors to navigate complex regulatory environments and reach diverse customer segments.

In the Asia-Pacific arena, rapid expansion of academic institutions, government-backed research initiatives, and a burgeoning pharmaceutical industry drive accelerated demand growth. Manufacturing capabilities in several countries have become increasingly sophisticated, leading to localized production of core reagents. To capture this opportunity, global suppliers are forging joint ventures, establishing regional R&D centers, and offering training programs designed to build technical expertise among end users.

Leadership Moves and Competitive Strategy Trends

Key industry players are leveraging a combination of innovation, strategic partnerships, and targeted acquisitions to solidify their positions. Leading reagent manufacturers have bolstered their portfolios through the acquisition of niche biotechnology firms specializing in novel labeling chemistries and next-generation probe technologies. Collaborative agreements with academic laboratories and clinical research organizations enable co-development of tailored solutions, facilitating early adoption and validation in real-world settings.

Investments in integrated platforms that bundle reagents with software-driven image analysis tools are emerging as a competitive differentiator. Companies extending their reach into adjacent segments, such as instrument manufacturers and digital pathology providers, are constructing end-to-end ecosystems that lock in customer loyalty. Additionally, a subset of agile innovators is carving out specialized niches by offering ultra-high-sensitivity reagents for emerging modalities like spatial transcriptomics and multiplex immuno-phenotyping.

Strategic Imperatives for Market Leadership in Imaging Reagents

To maintain a competitive edge, industry leaders must prioritize sustained investment in R&D pipelines, focusing on formulations that deliver enhanced signal-to-noise ratios, reduced background, and compatibility with advanced imaging platforms. Integrating artificial intelligence capabilities into reagent development can accelerate discovery of novel chemistries and optimize performance across diverse sample types. Diversification of the supply chain-through dual sourcing strategies and regional manufacturing footprints-will safeguard against future tariff fluctuations and logistical disruptions.

Strengthening collaborative relationships with end users via technical support, training initiatives, and co-development programs can drive deeper customer engagement and facilitate iterative product improvements. Embracing sustainability by reducing hazardous waste in reagent production and adopting eco-friendly packaging can resonate with increasingly conscientious purchasers. Finally, cultivating flexible commercial models-such as reagent leasing, subscription services, and volume-based discounts-can align with evolving procurement practices in academic and corporate research environments.

Rigorous Approach to Data Collection and Analysis

This report synthesizes insights gathered through a rigorous research framework combining primary interviews with senior scientists, procurement managers, and industry thought leaders, alongside an exhaustive review of proprietary company data, peer-reviewed literature, patent filings, and regulatory filings. Quantitative analyses were employed to validate qualitative themes, ensuring a balanced perspective across segmentation, regional dynamics, and competitive strategies.

Primary research engagements involved structured discussions with key opinion leaders representing academic and clinical institutions, pharmaceutical research units, and reagent manufacturers. Secondary research spanned industry databases, trade publications, and government reports, enabling cross-verification of market characteristics and emerging trends. Data triangulation techniques were applied to reconcile disparate sources and capture the nuanced impact of regulatory changes, supply chain shifts, and technological advancements.

Synthesis of Trends and Strategic Outlook

The advent of multiplexed imaging, digital pathology, and AI-powered analysis has irreversibly transformed the biological imaging reagent space. Segmentation insights reveal that customized reagent formulations and integrated assay platforms will drive differentiation, while regional considerations underscore the importance of localized strategies to unlock growth. Competitive dynamics have intensified as incumbent players and agile newcomers alike vie to deliver comprehensive solutions that streamline workflows and enhance reproducibility.

Looking ahead, the alignment of reagent innovation with open science initiatives, data transparency, and sustainability imperatives will shape stakeholder priorities. Decision-makers must weigh evolving regulatory landscapes and potential trade policy shifts when crafting procurement strategies. By leveraging the actionable intelligence within this report, organizations can anticipate market inflection points, optimize product portfolios, and fortify their supply chains in preparation for the next wave of imaging-led discoveries.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Antibodies
      • Primary Antibodies
      • Secondary Antibodies
    • Enzymes
      • Kinases
      • Proteases
    • Fluorescent Dyes
      • Organic Dyes
      • Quantum Dots
    • Probes
      • DNA Probes
      • RNA Probes
    • Stains
      • Gram Stains
      • Hematoxylin And Eosin
  • Technology
    • Bioluminescence Reagents
      • ATP Assays
      • Luciferase Substrates
    • Chemiluminescence Reagents
      • ECL Kits
      • HRP Substrates
    • Colorimetric Assays
      • Bradford Protein Assay
      • Elisa Kits
    • Fluorescence Microscopy Reagents
      • FISH Probes
      • Immunofluorescence Reagents
  • Application
    • Cell Biology
      • Apoptosis Assays
      • Cell Viability Assays
    • Drug Discovery
      • High Throughput Screening Reagents
      • Screening Assays
    • Molecular Biology
      • PCR Reagents
      • Western Blot Reagents
    • Pathology
      • FISH Probes
      • IHC Reagents
  • End User
    • Academic And Research Institutes
      • Research Institutes
      • Universities
    • Hospitals And Diagnostic Labs
      • Clinical Laboratories
      • Pathology Laboratories
    • Pharmaceutical And Biotechnology
      • Big Pharma
      • Pharma Outsourcing
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam plc
  • Bruker Corporation
  • Becton Dickinson and Company
  • General Electric Company

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biological Imaging Reagent Market, by Product Type
8.1. Introduction
8.2. Antibodies
8.2.1. Primary Antibodies
8.2.2. Secondary Antibodies
8.3. Enzymes
8.3.1. Kinases
8.3.2. Proteases
8.4. Fluorescent Dyes
8.4.1. Organic Dyes
8.4.2. Quantum Dots
8.5. Probes
8.5.1. DNA Probes
8.5.2. RNA Probes
8.6. Stains
8.6.1. Gram Stains
8.6.2. Hematoxylin And Eosin
9. Biological Imaging Reagent Market, by Technology
9.1. Introduction
9.2. Bioluminescence Reagents
9.2.1. ATP Assays
9.2.2. Luciferase Substrates
9.3. Chemiluminescence Reagents
9.3.1. ECL Kits
9.3.2. HRP Substrates
9.4. Colorimetric Assays
9.4.1. Bradford Protein Assay
9.4.2. Elisa Kits
9.5. Fluorescence Microscopy Reagents
9.5.1. FISH Probes
9.5.2. Immunofluorescence Reagents
10. Biological Imaging Reagent Market, by Application
10.1. Introduction
10.2. Cell Biology
10.2.1. Apoptosis Assays
10.2.2. Cell Viability Assays
10.3. Drug Discovery
10.3.1. High Throughput Screening Reagents
10.3.2. Screening Assays
10.4. Molecular Biology
10.4.1. PCR Reagents
10.4.2. Western Blot Reagents
10.5. Pathology
10.5.1. FISH Probes
10.5.2. IHC Reagents
11. Biological Imaging Reagent Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.2.1. Research Institutes
11.2.2. Universities
11.3. Hospitals And Diagnostic Labs
11.3.1. Clinical Laboratories
11.3.2. Pathology Laboratories
11.4. Pharmaceutical And Biotechnology
11.4.1. Big Pharma
11.4.2. Pharma Outsourcing
12. Americas Biological Imaging Reagent Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biological Imaging Reagent Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biological Imaging Reagent Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Merck KGaA
15.3.4. PerkinElmer, Inc.
15.3.5. Agilent Technologies Inc.
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. Abcam plc
15.3.8. Bruker Corporation
15.3.9. Becton Dickinson and Company
15.3.10. General Electric Company
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOLOGICAL IMAGING REAGENT MARKET MULTI-CURRENCY
FIGURE 2. BIOLOGICAL IMAGING REAGENT MARKET MULTI-LANGUAGE
FIGURE 3. BIOLOGICAL IMAGING REAGENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOLOGICAL IMAGING REAGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOLOGICAL IMAGING REAGENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOLOGICAL IMAGING REAGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY KINASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROTEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ORGANIC DYES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY QUANTUM DOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DNA PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RNA PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY GRAM STAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HEMATOXYLIN AND EOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ATP ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY LUCIFERASE SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ECL KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HRP SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BRADFORD PROTEIN ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IMMUNOFLUORESCENCE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APOPTOSIS ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL VIABILITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HIGH THROUGHPUT SCREENING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY SCREENING ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PCR REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY WESTERN BLOT REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FISH PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY IHC REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMA OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 116. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 118. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 119. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 120. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 121. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 122. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 124. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 125. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 126. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 127. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 129. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 130. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 131. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 132. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 134. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 135. CANADA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 239. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 240. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 241. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 242. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 243. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 245. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 246. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 247. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 248. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 250. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 251. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 252. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 253. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 255. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 256. GERMANY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 259. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 260. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 261. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 262. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 263. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 265. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 266. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 267. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 268. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 270. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 271. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 272. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 273. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 275. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 276. FRANCE BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 285. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 286. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY COLORIMETRIC ASSAYS, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENCE MICROSCOPY REAGENTS, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CELL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY MOLECULAR BIOLOGY, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 299. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 300. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY FLUORESCENT DYES, 2018-2030 (USD MILLION)
TABLE 301. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY PROBES, 2018-2030 (USD MILLION)
TABLE 302. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY STAINS, 2018-2030 (USD MILLION)
TABLE 303. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY BIOLUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 305. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY CHEMILUMINESCENCE REAGENTS, 2018-2030 (USD MILLION)
TABLE 306. ITALY BIOLOGICAL IMAGING REAGENT MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biological Imaging Reagent market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam plc
  • Bruker Corporation
  • Becton Dickinson and Company
  • General Electric Company

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.77 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biological Imaging Reagents - Global Strategic Business Report - Product Image

Biological Imaging Reagents - Global Strategic Business Report

  • Report
  • 340 Pages
  • Global
From
Biologic Imaging Reagents Market by Product Type, Imaging Modality, End User, Application - Global Forecast to 2030 - Product Image

Biologic Imaging Reagents Market by Product Type, Imaging Modality, End User, Application - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Biologic Imaging Reagents Market Report 2025 - Product Image

Biologic Imaging Reagents Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biological Sample Handling Market by Product Type, End User, Application, Sample Type, Workflow - Global Forecast to 2030 - Product Image

Biological Sample Handling Market by Product Type, End User, Application, Sample Type, Workflow - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Biological Reagent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Biological Reagent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 159 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.